Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Genmab A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Genmab A/S, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Genmab A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Genmab A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Genmab A/S, Medical Devices Deals, 2012 to YTD 2018 10
Genmab A/S, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Genmab A/S, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Genmab Acquires Antibody Assets from iDD Biotech 13
Partnerships 14
Mabimmune and Genmab Enter into Research Collaboration 14
Genmab Enters into Co-Development Agreement with BioNTech 15
BioNovion Enters into Agreement with Genmab to Discover and Develop Multiple Bispecific Antibody Products 16
Genmab Enters into Research Agreement with Seattle Genetics 17
Ventana Medical Systems Enters Into Co-Development Agreement With Genmab 18
MAB Discovery Enters into Research Agreement with Genmab for Therapeutic Antibody Products 19
Genmab Enters Into Co-Development Agreement With ADC Therapeutics 20
Genmab Enters into Co-Development Agreement with ADC Therapeutics 21
Genmab Enters Into Agreement With Kyowa Hakko Kirin For Bispecific Antibodies 22
Licensing Agreements 23
Genmab Enters into Licensing Agreement with Immatics Biotechnologies 23
Genmab Enters into Licensing Agreement with Gilead Sciences 24
Novo Nordisk Expands Licensing Agreement with Genmab 25
Genmab Enters into Licensing Agreement with Bristol-Myers Squibb 26
Genmab Enters into Licensing Agreement with Janssen Biotech for Daratumumab 27
Genmab Expands Licensing Agreement With Janssen Biotech 29
Genmab Enters into Licensing Agreement with Janssen Biotech for DuoBody Technology 30
Genmab Enters Into Licensing Agreement With Cormorant Pharma For HuMax-IL8 31
Open Monoclonal Technology Enters into Licensing Agreement with Genmab for OmniRat, OmniMouse and OmniFlic 32
Equity Offering 33
Genmab Raises USD1.2 Million in Private Placement of Shares up on Exercise of Warrants 33
Genmab to Raise USD4.8 Million in Private Placement of Shares upon Exercise of Warrants 34
Genmab Completes Private Placement of Shares for USD181.3 Million 35
Genmab Completes Private Placement Of Shares For US$2 Million Upon Exercise Of Warrants 36
Genmab Completes Private Placement Of Shares For US$5 Million Upon Exercise Of Warrants 37
Asset Transactions 38
Genmab Sells Brooklyn Park Manufacturing Facility To Baxter Healthcare For US$10 Million 38
Acquisition 39
Meditor European Master Fund Sells Its Stake In Genmab 39
Genmab A/S – Key Competitors 40
Genmab A/S – Key Employees 41
Genmab A/S – Locations And Subsidiaries 42
Head Office 42
Other Locations & Subsidiaries 42
Recent Developments 43
Financial Announcements 43
May 08, 2018: Genmab: Interim Report First Quarter 2018 43
Feb 21, 2018: Genmab 2017 Annual Report 44
Nov 08, 2017: Genmab Announces Financial Results for the First Nine Months of 2017 46
Aug 09, 2017: Genmab Announces Financial Results for the First Half of 2017 47
May 10, 2017: Genmab Announces Financial Results for the First Quarter of 2017 48
Feb 22, 2017: Genmab 2016 Annual Report 53
Jan 24, 2017: Genmab reports net sales for DARZALEX in 2016 54
Corporate Communications 55
Feb 08, 2017: Genmab Appoints Judith Klimovsky, MD, as Chief Development Officer 55
Product News 56
06/29/2018: HuMax-AXL-ADC Progress Triggers Milestone Payment to Seattle Genetics 56
05/17/2018: Genmab Announces to Present Abstract on CD3xCD20 at 23rd EHA Annual Congress 57
04/20/2017: Genmab To Present Poster Presentations On HuMax-AXL-ADC at 2017 ASCO Annual Meeting 58
Other Significant Developments 59
Dec 11, 2017: Genmab’s 2017 R&D Update 59
Appendix 60
Methodology 60
About GlobalData 60
Contact Us 60
Disclaimer 60
Genmab A/S, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Genmab A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Genmab A/S, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Genmab A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Genmab A/S, Deals By Therapy Area, 2012 to YTD 2018 9
Genmab A/S, Medical Devices Deals, 2012 to YTD 2018 10
Genmab A/S, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Genmab Acquires Antibody Assets from iDD Biotech 13
Mabimmune and Genmab Enter into Research Collaboration 14
Genmab Enters into Co-Development Agreement with BioNTech 15
BioNovion Enters into Agreement with Genmab to Discover and Develop Multiple Bispecific Antibody Products 16
Genmab Enters into Research Agreement with Seattle Genetics 17
Ventana Medical Systems Enters Into Co-Development Agreement With Genmab 18
MAB Discovery Enters into Research Agreement with Genmab for Therapeutic Antibody Products 19
Genmab Enters Into Co-Development Agreement With ADC Therapeutics 20
Genmab Enters into Co-Development Agreement with ADC Therapeutics 21
Genmab Enters Into Agreement With Kyowa Hakko Kirin For Bispecific Antibodies 22
Genmab Enters into Licensing Agreement with Immatics Biotechnologies 23
Genmab Enters into Licensing Agreement with Gilead Sciences 24
Novo Nordisk Expands Licensing Agreement with Genmab 25
Genmab Enters into Licensing Agreement with Bristol-Myers Squibb 26
Genmab Enters into Licensing Agreement with Janssen Biotech for Daratumumab 27
Genmab Expands Licensing Agreement With Janssen Biotech 29
Genmab Enters into Licensing Agreement with Janssen Biotech for DuoBody Technology 30
Genmab Enters Into Licensing Agreement With Cormorant Pharma For HuMax-IL8 31
Open Monoclonal Technology Enters into Licensing Agreement with Genmab for OmniRat, OmniMouse and OmniFlic 32
Genmab Raises USD1.2 Million in Private Placement of Shares up on Exercise of Warrants 33
Genmab to Raise USD4.8 Million in Private Placement of Shares upon Exercise of Warrants 34
Genmab Completes Private Placement of Shares for USD181.3 Million 35
Genmab Completes Private Placement Of Shares For US$2 Million Upon Exercise Of Warrants 36
Genmab Completes Private Placement Of Shares For US$5 Million Upon Exercise Of Warrants 37
Genmab Sells Brooklyn Park Manufacturing Facility To Baxter Healthcare For US$10 Million 38
Meditor European Master Fund Sells Its Stake In Genmab 39
Genmab A/S, Key Competitors 40
Genmab A/S, Key Employees 41
Genmab A/S, Subsidiaries 42
List of Figures
Genmab A/S, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Genmab A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Genmab A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Genmab A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Genmab A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Genmab A/S, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Genmab A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Genmab A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Genmab A/S, Medical Devices Deals, 2012 to YTD 2018 10